Ghost Tree Capital, LLC Spectrum Pharmaceuticals Inc Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.83 - $3.45 $70,162 - $132,273	-38,340 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $134,190 - $396,819	38,340 New	38,340 $140,000
Q4 2018 Feb 14, 2019	SELL	$6.39 - $16.99 $301,608 - $801,927	-47,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $300,664 - $451,724	18,200 Added 62.76%	47,200 $793,000
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $414,990 - $630,750	29,000 New	29,000 $608,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.